By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Generic drugmaker Sandoz expects unbranded versions of Novo Nordisk's ...

From oral drops falsely marketed as GLP-1 alternatives to unauthorized smartwatches claiming to monitor blood sugar without a single finger prick, a wave of fraudulent diabetes-related products are ...

Ozempic, Wegovy and other GLP-1 medications have gained widespread popularity for weight loss and diabetes control in recent years — but the spike in demand has made it difficult for some people to ...

ORLANDO, Florida — A low dose of the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin combined with insulin improved glycemic control and slowed kidney function decline in adolescents ...